or Try an Advanced Search...

    Technical Analysis for IMNM - Immunome, Inc.

    Grade Last Price % Change Price Change
    F 9.65 3.38% 0.32
    IMNM closed down 0.64 percent on Wednesday, November 20, 2024, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IMNM trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 3.38%
    Lizard Bullish Bullish Day Trade Setup 3.38%
    Narrow Range Bar Range Contraction 3.38%
    Lower Bollinger Band Walk Weakness 3.38%
    Wide Bands Range Expansion 3.38%
    Down 3 Days in a Row Weakness 3.38%
    Down 4 Days in a Row Weakness 3.38%
    Down 5 Days in a Row Weakness 3.38%
    Lower Bollinger Band Touch Weakness 3.38%
    Oversold Stochastic Weakness 3.38%
    Older End-of-Day Signals for IMNM ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    Lower Bollinger Band Support about 3 hours ago
    Lizard Bullish Entry about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IMNM Chart by TradingView
    Basic chart:

    Profile

    Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Tumor Cancer Immunotherapy Monoclonal Antibodies Monoclonal Antibody Antibody Glycoproteins Antigen Symphogen

    Is IMNM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 13 Immunome, Inc GAAP EPS of -$0.78 misses by $0.21
    Nov 13 Immunome, Inc. (IMNM) Reports Q3 Loss, Misses Revenue Estimates
    Nov 13 Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 12 ImmunityBio (IBRX) Reports Q3 Loss, Tops Revenue Estimates
    Nov 5 Immunome to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
    Oct 29 Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
    Oct 18 Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium
    Oct 8 Immunome files to sell 230K shares of common stock for holders
    Oct 8 Immunome Appoints Roee Shahar as Executive Vice President, Commercial
    See more IMNM news...

    Comments

    T

    TraderMike 10 months ago

    I was in the right place at the right time on this today. 🎉  I actually bought it yesterday after it made a (you guessed it) 
    Non-ADX 1,2,3,4 Bullish     signal the day before.  I sold half around 21 and am still holding the other half of the shares.  

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 30.958
    52 Week Low 6.93
    Average Volume 770,553
    200-Day Moving Average 16.06
    50-Day Moving Average 12.81
    20-Day Moving Average 11.75
    10-Day Moving Average 11.21
    Average True Range 0.79
    RSI (14) 28.06
    ADX 23.5
    +DI 11.89
    -DI 36.24
    Chandelier Exit (Long, 3 ATRs) 11.30
    Chandelier Exit (Short, 3 ATRs) 11.33
    Upper Bollinger Bands 14.24
    Lower Bollinger Band 9.25
    Percent B (%b) 0.02
    BandWidth 42.50
    MACD Line -0.79
    MACD Signal Line -0.47
    MACD Histogram -0.3204
    Fundamentals Value
    Market Cap 420.11 Million
    Num Shares 45 Million
    EPS -1.80
    Price-to-Earnings (P/E) Ratio -5.18
    Price-to-Sales 105.68
    Price-to-Book 174.08
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.92
    Resistance 3 (R3) 9.86 9.61 9.82
    Resistance 2 (R2) 9.61 9.46 9.64 9.78
    Resistance 1 (R1) 9.47 9.37 9.54 9.53 9.75
    Pivot Point 9.22 9.22 9.26 9.25 9.22
    Support 1 (S1) 9.08 9.07 9.15 9.14 8.91
    Support 2 (S2) 8.83 8.98 8.86 8.88
    Support 3 (S3) 8.69 8.83 8.84
    Support 4 (S4) 8.75